19 June 2013
Keywords: avastin, herceptin, her2, study, initiated, international, beth
Article | 09 June 2008
The international BETH study for women with HER2-positive breast cancer is open for enrollment. The pivotal Phase III clinical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 June 2008
26 May 2008
18 June 2013
© 2013 thepharmaletter.com